Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

Scribe Therapeutics Inc. — Funding, Investors & Profile — Capbase

← All companies

Compare History

Scribe Therapeutics Inc.

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: E9LNGD3EP3H8

Founded: —Source: [GOV]
Headquarters: BERKELEY, CaliforniaSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

Scribe Therapeutics Inc. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $299,700 in 2019. These are non-dilutive federal research grants, not equity financing. The company is based in BERKELEY, California.

Funding rounds

2 rounds

SBIR Phase I award (HHS)GrantFeb 2019Source: [GOV]
$149.8K
—post-money
SBIR Phase I award (HHS)

Investors

No investors recorded yet for Scribe Therapeutics Inc..

Add an investor

People

Leadership

BENJAMIN L OAKESPrincipal investigatorSince 2019Source: [GOV]

BRETT T STAAHLPrincipal investigatorSince 2019Source: [GOV]

Acquisitions

Scribe Therapeutics Inc. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for Scribe Therapeutics Inc..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Jun 2019Source: [GOV]

$149.8K

—post-money